GLN2 as a key biomarker and therapeutic target: evidence from a comprehensive pan-cancer study using molecular, functional, and bioinformatic analyses

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clin. 2022;72(1):7–33.

Article  Google Scholar 

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang D, Liu B, Zhang Z. Accelerating the understanding of cancer biology through the lens of genomics. Cell. 2023;186(8):1755–71.

Article  CAS  PubMed  Google Scholar 

Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, Wang Q, Li X, Zhang Y, Xu J. Molecular characterization and clinical relevance of m 6 a regulators across 33 cancer types. Mol Cancer. 2019;18:1–6.

Article  PubMed  PubMed Central  Google Scholar 

Zheng H, Wang M, Zhang S, Hu D, Yang Q, Chen M, Zhang X, Zhang Y, Dai J, Liou YC. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int J Biol Sci. 2023;19(14):4689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Essers PB, Pereboom TC, Goos YJ, Paridaen JT, MacInnes AW. A comparative study of nucleostemin family members in zebrafish reveals specific roles in ribosome biogenesis. Dev Biol. 2014;385(2):304–15.

Article  CAS  PubMed  Google Scholar 

Paridaen JTML, Janson E, Utami KH, Pereboom TC, Essers PB, van Rooijen C, Zivkovic D, MacInnes AW. The nucleolar GTP-binding proteins Gnl2 and nucleostemin are required for retinal neurogenesis in developing zebrafish. Dev Biol. 2011;355(2):286–301.

Article  CAS  PubMed  Google Scholar 

Datta D, Anbarasu K, Rajabather S, Priya RS, Desai P, Mahalingam S. Nucleolar GTP-binding protein-1 (NGP-1) promotes G1 to S phase transition by activating cyclin-dependent kinase inhibitor p21Cip1/Waf1. J Biol Chem. 2015;290(35):21536–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iuchi S, Paulo JA. RNAmetasome network for macromolecule biogenesis in human cells. Commun Biol. 2021;4(1):1399.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006;5(1):1–25.

Article  Google Scholar 

Dong Y, Cai Q, Fu L, Liu H, Ma M, Wu X. Study of the G protein nucleolar 2 value in liver hepatocellular carcinoma treatment and prognosis. Biomed Res Int. 2021;2021:4873678.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura K, Reid BM, Chen A, Chen Z, Goode EL, Permuth JB, Teer JK, Tyrer J, Yu X, Kanetsky PA. Functional analysis of the 1p34. 3 risk locus implicates GNL2 in high-grade serous ovarian cancer. Am J Hum Genet. 2022;109(1):116–35.

Article  CAS  PubMed  Google Scholar 

Wei S, Lu K, Xing J, Yu W. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. FASEB J. 2023;37(4):e22849.

Article  CAS  PubMed  Google Scholar 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.

Article  PubMed  Google Scholar 

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.

Article  PubMed  PubMed Central  Google Scholar 

Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z. CancerSEA: a cancer single-cell state atlas. Nucl Acid Res. 2019;47(D1):D900-8.

Article  CAS  Google Scholar 

Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008;4(11):e1000217.

Article  PubMed  PubMed Central  Google Scholar 

Veres DV, Gyurkó DM, Thaler B, Szalay KZ, Fazekas D, Korcsmáros T, Csermely P. ComPPI: a cellular compartment-specific database for protein–protein interaction network analysis. Nucl Acid Res. 2015;43(D1):D485-93.

Article  CAS  Google Scholar 

Dempster JM, Boyle I, Vazquez F, Root DE, Boehm JS, Hahn WC, Tsherniak A, McFarland JM. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 2021;22:1–23.

Article  Google Scholar 

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2. 0 for analysis of tumor-infiltrating immune cells. Nucl Acid Res. 2020;48(W1):W509-14.

Qiu C, Shi W, Wu H, Zou S, Li J, Wang D, Liu G, Song Z, Xu X, Hu J, Geng H. Identification of molecular subtypes and a prognostic signature based on inflammation-related genes in colon adenocarcinoma. Front Immunol. 2021;12:769685.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng D, Zhu W, Shi X, Wang Z, Wei W, Wei Q, Yang L, Han P. Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy. Exp Hematol Oncol. 2023;12(1):8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi Q, Pu Y, Chao F, Bian P, Lv L. ACAP1 deficiency predicts inferior immunotherapy response in solid tumors. Cancers (Basel). 2022;14(23).

Hasan S. Effects of plyometric vs. strength training on strength, sprint, and functional performance in soccer players: a randomized controlled trial. Sci Rep. 2023;13(1):4256.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ. Comparative toxicogenomics database (CTD): update 2021. Nucl Acid Res. 2021;49(D1):D1138-43.

Liu CJ, Fe H, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.

Article  PubMed  Google Scholar 

Reinhold WC, Wilson K, Elloumi F, Bradwell KR, Ceribelli M, Varma S, Wang Y, Duveau D, Menon N, Trepel J. CellMinerCDB: NCATS is a web-based portal integrating public cancer cell line databases for pharmacogenomic explorations. Cancer Res. 2023;83(12):1941–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang C, Zhang H, Chen M, Wang S, Qian R, Zhang L, Huang X, Wang J, Liu Z, Qin W. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. Elife. 2022;11:e71880.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sepulveda JL. Using R and bioconductor in clinical genomics and transcriptomics. J Mol Diagn. 2020;22(1):3–20.

Article  CAS  PubMed  Google Scholar 

Schober P, Vetter TR. Kaplan-Meier curves, log-rank tests, and cox regression for time-to-event data. Anesth Analgesia. 2021;132(4):969–70.

Article  Google Scholar 

Duan J, Zhu L, Shi Y, Wang W, Wang T, Ning T, Zhang L, Bai M, Li H, Liu R. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer. 2024;24(1):302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang T-HO, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA. The immune landscape of cancer. Immunity. 2018;48(4):812–30.

Article  CAS 

留言 (0)

沒有登入
gif